There have been several updates for orthopedic and spine device companies this past week, as financial reports are released and new products launched.
Here are key investor notes on six device companies:
1. LDR Holdings CEO Christophe Lavigne sold 25,000 shares of company stock on Nov. 17 at an average price of $34.03. The entire transaction was valued at $850,750, and Mr. Lavigne now directly owns 908,827 shares in the company, valued at around $30.9 million. A month ago, JMP Securities reiterated a "market outperform" rating on the company, according to a Watch List News report.
2. Aurora Spine share price jumped 12.5 percent on Nov. 18 after the company announced the FDA cleared its ZIP 51 TM spinal fusion implant, the company's fifth clearance in 11 months, according to a Stock House report. The market cap was reported as $28.2 million after the much-needed jump. The company still has a ways to go before again reaching its 52-week high of $6.60.
3. Amedica's stock fell 2.21 percent recently to $1.33. Earlier this month, the company signed a multi-year original equipment manufacturer agreement with Spinal Kinetics. The company's short and long term trend has been down since June 3, according to a Market Club report.
4. NuVasive was recently upgraded by Wells Fargo & Co., from "market perform" to "outperform" on Nov. 17. The company's CEO Alex V. Lukianov also sold 25,000 shares of company stock on the open market earlier this month for a total value of slightly more than $1 million. The stock was sold at an average price of $41.40, according to a Sleek Monkey report.
5. Stryker is currently valued at $33.99 billion and closed the last trading session at $88.53. The company recently settled a lawsuit over a 2012 hip implant recall. The company set aside $1.4 billion to cover costs, but will likely pay more. Despite the lawsuit, stock has a 50-day moving average of $83.84, higher than the $82.70 for the 200 day moving average, according to a Markets Wired report.
6. K2M's stock hit a new 52-week high on Nov. 18, directly after appearing at the North American Spine Society annual meeting. The stock traded as high as $18.49, and was last traded at $18, according to a Sleek Monkey report. The stock has a 50-day moving average of $15.13 and the company's market cap is $698.2 million.